Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ira M Jacobson

Showing results (81-90 of 186) with videos related to

Pageof 19
Sort By:
Journal of Hepatology|December 17, 2013
Minimal impact of sofosbuvir and ribavirin on health related quality of life in chronic hepatitis C (CH-C)Zobair M Younossi, Maria Stepanova, Linda Henry, et al.
The Journal of Family Practice|April 20, 2010
Entering the new era of therapy for HBV and HCV infectionsMarion G Peters, Robert P Perrillo, Ira M Jacobson, et al.
Hepatology (Baltimore, Md.)|November 17, 2023
Prevalence and characteristics of hepatitis delta virus infection in patients with hepatitis B in the United States: An analysis of the All-Payer Claims DatabaseRobert G Gish, Ira M Jacobson, Joseph K Lim, et al.
Journal of Viral Hepatitis|August 17, 2018
Disparities in mortality for chronic liver disease among Asian subpopulations in the United States from 2007 to 2016Andrew A Li, Donghee Kim, Won Kim, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 11, 2004
Hepatocyte proliferation in chronic hepatitis C: correlation with degree of liver disease and serum alpha-fetoproteinP Wilfredo Canchis, Stevan A Gonzalez, M Isabel Fiel, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 10, 2013
Effects of sofosbuvir-based treatment, with and without interferon, on outcome and productivity of patients with chronic hepatitis CZobair M Younossi, Maria Stepanova, Linda Henry, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 30, 2021
Treatment Algorithm for Managing Chronic Hepatitis B Virus Infection in the United States: 2021 UpdatePaul Martin, Mindie H Nguyen, Douglas T Dieterich, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 19, 2015
A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: 2015 UpdatePaul Martin, Daryl T-Y Lau, Mindie H Nguyen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 16, 2004
A treatment algorithm for the management of chronic hepatitis B virus infection in the United StatesEmmet B Keeffe, Douglas T Dieterich, Steve-Huy B Han, et al.
The New England Journal of Medicine|May 1, 2009
Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infectionJohn G McHutchison, Gregory T Everson, Stuart C Gordon, et al.
Pageof 19

Showing results (81-90 of 186) with videos related to

Sort By:
Pageof 19
Journal of Hepatology|December 17, 2013
Minimal impact of sofosbuvir and ribavirin on health related quality of life in chronic hepatitis C (CH-C)Zobair M Younossi, Maria Stepanova, Linda Henry, et al.
The Journal of Family Practice|April 20, 2010
Entering the new era of therapy for HBV and HCV infectionsMarion G Peters, Robert P Perrillo, Ira M Jacobson, et al.
Hepatology (Baltimore, Md.)|November 17, 2023
Prevalence and characteristics of hepatitis delta virus infection in patients with hepatitis B in the United States: An analysis of the All-Payer Claims DatabaseRobert G Gish, Ira M Jacobson, Joseph K Lim, et al.
Journal of Viral Hepatitis|August 17, 2018
Disparities in mortality for chronic liver disease among Asian subpopulations in the United States from 2007 to 2016Andrew A Li, Donghee Kim, Won Kim, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 11, 2004
Hepatocyte proliferation in chronic hepatitis C: correlation with degree of liver disease and serum alpha-fetoproteinP Wilfredo Canchis, Stevan A Gonzalez, M Isabel Fiel, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 10, 2013
Effects of sofosbuvir-based treatment, with and without interferon, on outcome and productivity of patients with chronic hepatitis CZobair M Younossi, Maria Stepanova, Linda Henry, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 30, 2021
Treatment Algorithm for Managing Chronic Hepatitis B Virus Infection in the United States: 2021 UpdatePaul Martin, Mindie H Nguyen, Douglas T Dieterich, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 19, 2015
A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: 2015 UpdatePaul Martin, Daryl T-Y Lau, Mindie H Nguyen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 16, 2004
A treatment algorithm for the management of chronic hepatitis B virus infection in the United StatesEmmet B Keeffe, Douglas T Dieterich, Steve-Huy B Han, et al.
The New England Journal of Medicine|May 1, 2009
Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infectionJohn G McHutchison, Gregory T Everson, Stuart C Gordon, et al.
Pageof 19